Marek Bolanowski
Overview
Explore the profile of Marek Bolanowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
198
Citations
1422
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Elbaum M, Kaluzny M, Jawiarczyk-Przybylowska A, Wojtczak B, Zembska A, Bolanowski M
Endokrynol Pol
. 2025 Mar;
76(1):86-93.
PMID: 40071804
Introduction: The analysis of the costs associated with treating acromegaly and its complications is important in planning diagnostics and treatment for a single patient, as well as in establishing the...
2.
Zdrojowy-Welna A, Bolanowski M, Syrycka J, Jawiarczyk-Przybylowska A, Kuliczkowska-Plaksej J
Front Oncol
. 2025 Mar;
15:1492187.
PMID: 40071083
Ectopic adrenocorticotropic hormone secretion (EAS) is responsible for approximately 10%-18% of Cushing's syndrome cases. Thymic neuroendocrine tumors (NETs) comprise 5%-16% of EAS; therefore, they are very rare and the data...
3.
Kocelak P, Owczarek A, Mossakowska M, Puzianowska-Kuznicka M, Bolanowski M, Olszanecka-Glinianowicz M, et al.
Clin Endocrinol (Oxf)
. 2025 Feb;
PMID: 39991800
Objective: There is limited data concerning the effect of untreated subclinical thyroid disorders on mortality in older adults. Therefore, this study aimed to analyze 5-year overall mortality among participants in...
4.
Halupczok-Zyla J, Jawiarczyk-Przybylowska A, Bolanowski M
Front Endocrinol (Lausanne)
. 2025 Jan;
15:1472680.
PMID: 39741885
Introduction: Acromegaly is a disease characterized by enhanced bone turnover with persistently high vertebral fracture risk. Sclerostin is a glycoprotein, which acts as an inhibitor of bone formation and activates...
5.
Witek P, Bolanowski M, Kretowski A, Glowinska A
Front Endocrinol (Lausanne)
. 2024 Dec;
15:1455465.
PMID: 39735646
Pasireotide is an effective treatment for both Cushing's disease (CD) and acromegaly due to its ability to suppress adrenocorticotropic hormone and growth hormone, and to normalize insulin-like growth factor-1 levels,...
6.
Strzelec M, Rolla M, Kuliczkowska-Plaksej J, Kaluzny M, Sloka N, Wronowicz J, et al.
J Clin Med
. 2024 Nov;
13(22).
PMID: 39597993
Neoplasms are one of the three most common causes of death in patients with acromegaly. Our study aimed to assess the incidence of benign and malignant neoplasms among patients with...
7.
Skrzypiec-Spring M, Kuliczkowska-Plaksej J, Szelag A, Bolanowski M
Endocrinol Diabetes Metab Case Rep
. 2024 Oct;
2024(4).
PMID: 39475827
Summary: Relative energy deficiency in sport occurs in athletes who have limited energy availability. Its typical features include reversible suppression of the hypothalamic-pituitary-gonadal axis. In addition, it may be accompanied...
8.
Gurwin A, Karwacki J, Dorochowicz M, Kowalczyk K, Nowak L, Jedrzejuk D, et al.
J Clin Med
. 2024 Sep;
13(17).
PMID: 39274339
This study assessed the topography and lateralization of lymph node (LN) metastases in muscle-invasive bladder cancer (MIBC) patients using super-extended pelvic lymph node dissection (sePLND) with sentinel lymph node dissection...
9.
Sobczuk J, Paczkowska K, Andrusiow S, Bolanowski M, Daroszewski J
Biomolecules
. 2024 Aug;
14(8).
PMID: 39199306
Alzheimer disease, the leading cause of dementia, and polycystic ovary syndrome, one of the most prevalent female endocrine disorders, appear to be unrelated conditions. However, studies show that both disease...
10.
Zdrojowy-Welna A, Stachowska B, Bolanowski M
Pituitary
. 2024 Jul;
27(6):837-846.
PMID: 39008229
Bone impairment associated with Cushing's disease (CD) is a complex disorder, mainly involving deterioration of bone quality and resulting in an increased fracture rate, often despite normal bone mineral density....